Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11751939 | 0.90 | KDM4E (0.44) | LMNAKDM4EHPGDNPY5RNPSR1 | |
| SCHEMBL18157316 | 0.86 | LMNA (0.38) | LMNAL3MBTL1KDM4EHPGDNPSR1 | |
| SCHEMBL11752950 | 0.83 | KDM4E (0.44) | LMNAKDM4EHPGDNPY5RNPSR1 | |
| SCHEMBL18157314 | 0.81 | KDM4E (0.38) | LMNAKDM4EHPGDNPY5RNPSR1 | |
| SCHEMBL2008228 | 0.80 | NPSR1 (0.41) | HPGDNPSR1EGFRKCNH2TSHR | |
| SCHEMBL24325397 | 0.78 | CTSB (0.44) | LMNAL3MBTL1KDM4EHPGDNPY5R | |
| SCHEMBL915976 | 0.78 | CYP2C9 (0.41) | NPY5RNPSR1EGFRKCNH2NR1I2 | |
| SCHEMBL6787119 | 0.78 | IMPDH2 (0.43) | LMNAKDM4EHPGDNPY5RNPSR1 | |
| SCHEMBL1773883 | 0.78 | ACP3 (0.57) | LMNAL3MBTL1KDM4EHPGDNPY5R | |
| SCHEMBL702504 | 0.77 | NPSR1 (0.47) | LMNAKDM4EHPGDNPSR1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663447-B2 | Asymmetric butadiene-based charge transport compound, electrophotographic photoreceptor containing same, and image forming apparatus | S-PRINTING SOLUTION CO., LTD. (KR) | 2017-05-30 | — | — | US | disclosed |
| US-9663447-B2 | Asymmetric butadiene-based charge transport compound, electrophotographic photoreceptor containing same, and image forming apparatus | S-PRINTING SOLUTION CO., LTD. (KR) | 2017-05-30 | — | — | US | disclosed |
| US-20160304437-A1 | ASYMMETRIC BUTADIENE-BASED CHARGE TRANSPORT COMPOUND, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CONTAINING SAME, AND IMAGE FORMING APPARATUS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| US-20160304437-A1 | ASYMMETRIC BUTADIENE-BASED CHARGE TRANSPORT COMPOUND, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CONTAINING SAME, AND IMAGE FORMING APPARATUS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304437-A1 | ASYMMETRIC BUTADIENE-BASED CHARGE TRANSPORT COMPOUND, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CONTAINING SAME, AND IMAGE FORMING APPARATUS | ALDH1A2, USE1, SLC9A1 | LMNA 2243/4885L3MBTL1 3742/4885KDM4E 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.